Journal List > J Korean Med Sci > v.36(38) > 1147525

Jo, Kim, Choe, Lee, Chang, Jung, Kang, Park, Kim, and Oh: Work Restrictions for Healthcare Personnel with Potential In-hospital Exposure to SARS-CoV-2: Experience at a Tertiary Hospital

Abstract

Applying work restrictions for asymptomatic healthcare personnel (HCP) with potential exposure to coronavirus disease 2019 (COVID-19) is recommended to prevent transmission from potentially contagious HCP to patients and other HCP. However, it can lead to understaffing, which threatens the safety of both patients and HCP. We evaluated 203 COVID-19 exposure events at a single tertiary hospital from January 2020 to June 2021. A total of 2,365 HCP were potentially exposed, and work restrictions were imposed on 320 HCP, leading to the loss of 3,311 working days. However, only one of the work-restricted HCP was confirmed with COVID-19. During the study period, the work restriction measures might be taken excessively compared to their benefit, so establishing more effective standards for work restriction is required.

Graphical Abstract

jkms-36-e274-abf001.jpg

Coronavirus disease 2019 (COVID-19) is a respiratory infectious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), mainly spread through droplets and is known to be spreadable through aerosols in particular circumstances.1 In a healthcare setting, hospitalized patients are more likely to be elderly with multiple comorbidities, so the risk of developing severe COVID-19 is high,2 and healthcare personnel (HCP) may serve as reservoirs, vectors, or victims of SARS-CoV-2 transmission between hospitals and communities.3 Therefore, preventing the nosocomial spread of SARS-CoV-2 is essential, but it is challenging.
To evaluate the preventive measures for the potential exposure events of COVID-19 in the hospital, we retrospectively reviewed all in-hospital COVID-19 exposure events from January 19, 2020 to June 15, 2021, at a tertiary hospital located in Seoul, Korea. The study hospital is a 1,761 bed university-affiliated tertiary hospital with over 8,600 HCP, including 1,947 doctors and 2,916 nurses, and treats about 540,000 inpatients and 2,230,000 outpatients annually.4 The study period was from the beginning of the COVID-19 outbreak in Korea to the completion of vaccination for the most HCP at the study hospital. When HCP were accidentally exposed to confirmed SARS-CoV-2 patients in the hospital, the level of risk was assessed through epidemiological investigation by national guidelines. Then, one of the preventive measures among passive monitoring, active monitoring, and self-quarantine, was applied to the HCP based on the level of the risk, and the final action was decided by the head of the local public health center. For the passive monitoring group, HCP self-assessed their symptoms and received SARS-CoV-2 reverse transcription polymerase chain reaction (RT-PCR) selectively. We checked their symptoms twice daily for the active monitoring group and recommended SARS-CoV-2 RT-PCR, but performed selectively. We also applied work restrictions for some of the active monitoring group, of which duration was determined case by case. The HCP in the self-quarantine group were restricted from working for 2 weeks after the last exposure.
During the study period, a total of 203 in-hospital COVID-19 exposure events occurred. The occurrence of the exposure events showed a similar trend to the number of daily confirmed cases in Korea (Fig. 1).5 Of 203 index cases, 124 (61.1%) were patients, followed by 53 (26.1%) visitors, and 26 (12.8%) HCP. Due to the events, a total of 2,365 HCP were potentially exposed to COVID-19 and preventive measures were applied; 1,706 (72.1%) passive monitoring, 339 (14.3%) active monitoring only, 119 (5.0%) active monitoring with work restriction, and 201 (8.5%) self-quarantine. Total work loss from the restriction was 3,311 person-days.
Of 203 exposure events, 45 events resulted in HCP work restrictions, and the index case was HCP or patient except for one case of which the index case was a visitor. There was a significant difference in the possibility of HCP work restrictions depending on the index case (16.9% in the patient index vs. 88.5% in the HCP index, P < 0.001). From 23 events with HCP index, a total of 117 (median, 5; IQR, 2–7.5 per event) HCP was work-restricted, and total work loss was 1,594 person-days (median 70, IQR 28-105 per event). From 21 events with patient index, a total of 199 (median, 2; IQR, 1–4 per event) HCP were work-restricted, and total work loss was 1,683 person-days (median, 18; IQR, 14–46 per event). When the index cases were HCP, more HCP were work-restricted (5 vs. 2, P = 0.041), for longer duration (70 person-days vs. 18 person-days, P = 0.028). Furthermore, in 10 events, exposed places such as the general ward, intensive care unit, emergency room, and chemotherapy daycare center were closed due to a shortage of HCP. It resulted in considerable catastrophic consequences such as delays in treatment for emergency patients and delays in chemotherapy for cancer patients. For example, when a surgeon was confirmed to COVID-19, 11 surgeons were removed from work for 14 days due to preventive measures. As a result, operation room was partially closed for 14 days, and 16 cancer surgeries were canceled or postponed. Summary of exposure events statistics is presented in Table 1.
Only one confirmed case was presumed to be infected by in-hospital exposure to SARS-CoV-2 from the self-quarantine group. The confirmed case was a doctor, classified as a self-quarantine group after his co-worker confirmed to COVID-19. He used the same room without wearing a mask with the index case a half to an hour every day. He was asymptomatic but confirmed with COVID-19 13-days after the last exposure, which was one day before the date of the confirmed date of his co-worker, during the self-quarantine period.
There is no doubt that preventing the nosocomial spread of SARS-CoV-2 is essential. SARS-CoV-2 can be transmitted from people without symptoms, and one modeling study found that more than half of all transmissions were from asymptomatic individuals.6 Therefore, a more conservative approach to HCP monitoring and applying work restriction is recommended. However, when implementing public health measures, we also consider its effectiveness, proportionality, necessity, and least infringement.7
Our study might suggest that the risk of transmission from patients with COVID-19 to HCP is low when HCP followed general infection control principles. In the previous studies, frontline HCP with appropriate personal protective equipment did not appear to be at higher risk of COVID-19,8 and there was no transmission of SARS-CoV-2 from patients in hundreds of close contacts including aerosol-generating procedures,910 which is consistent with our findings. Hence, it is questionable whether excessively taken preventive measures are effective. Furthermore, preventive measures for HCP might have been taken beyond the national guideline, probably due to excessive fear for a nosocomial outbreak, desire to avoid responsibility, and difficulty assessing the risk of exposure.
In the era of the COVID-19 pandemic, there are negative impacts not only on COVID-19 patients but also on non-COVID-19 patients.1112 Causes of this impact are multifactorial, but lack of medical resources is one of them. In the case of significant exposure events in our experience, many HCP were work-restricted simultaneously, and wards and emergency rooms were closed, drawing delays in the provision of critical medical care such as managing emergent patients and chemotherapy for cancer patients. From the beginning of the COVID-19 pandemic, large hospitals in Korea experienced a shortage of staff and partial to complete closure due to nosocomial COVID-19 infection,13 and there have been concerns about extreme preventive measures.14 Although the damage caused by extreme preventive measures is not directly visible; it may exceed the benefit of preventing the nosocomial spread of SARS-CoV-2.
In this study, the impacts of in-hospital COVID-19 exposure events were more significant when the index case was HCP compared to other cases. This seems to be because HCP followed the recommended routine infection prevention and control practices including wearing appropriate personal protective equipment while caring for patients, but there were more situations where HCP could not wear a mask, such as eating and drinking while socializing with their colleagues. Therefore, to reduce the adverse impact caused by potential exposure event of COVID-19 in hospital, it is necessary to create an environment in which HCP can adhere to the recommendation such as universal masking.
Increasing vaccination coverage among HCP might diminish the adverse impact of COVID-19 exposure events in a healthcare setting. Recent guidelines suggested that asymptomatic HCP who have had a higher-risk exposure do not require work restriction if they have been fully vaccinated.15 However, the emergence of variant strain and the possibility of breakthrough infection remind us that the preventive measures in healthcare setting should not rely solely on vaccines, and we should seek the balanced preventive measures. According to some published reports, secondary infection from non-isolated patients with COVID-19 to HCP not wearing recommended personal protective equipment is low, especially when the contact time is less than an hour.10161718192021 Therefore, relaxing criteria of close contact may be one way, and continuous effort to find an additional way is necessary.
Our study has several limitations. First, this is a retrospective, single-center (with hospital-specific infection control guidelines) study in a low prevalence country, so generalization is limited. Second, SARS-CoV-2 RT-PCR was not performed in all passive and active monitoring cases, so there is a possibility of missing asymptomatic infection.
In conclusion, current preventive measures after in-hospital COVID-19 exposure events might be excessive compared to its benefit and establishing stricter standards of work restriction may benefit both HCP and patients.

Ethics statement

The present study protocol was reviewed and approved by the Institutional Review Board (IRB) of Seoul National University Hospital (IRB No. 2106-191-1231). Informed consent was waived because of the retrospective nature of the study.

ACKNOWLEDGMENTS

We appreciated the Epidemic Intelligence Service Officers for their dedication to the epidemiological investigation and contact-tracing of in-hospital exposure events.

Notes

Funding: Funding for this project was supported by the research fund of Seoul National University Hospital (Grant No. 04-2021-0010). The funding agencies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Disclosure: The authors have no potential conflicts of interest to disclose.

Author Contributions:

  • Conceptualization: Choe PG.

  • Data curation: Jo HJ, Choe PG, Kim JS, Lee HY, Jung H.

  • Formal analysis: Jo HJ, Choe PG, Chang E, Kang CK, Park WB, Kim NJ, Oh MD.

  • Funding acquisition: Oh MD.

  • Investigation: Jo HJ, Kim JS, Lee HY, Jung H.

  • Methodology: Jo HJ, Choe PG.

  • Supervision: Choe PG, Oh MD.

  • Validation: Jo HJ, Choe PG.

  • Writing - original draft: Jo HJ, Choe PG.

  • Writing - review & editing: Jo HJ, Kim JS, Choe PG, Lee HY, Chang E, Jung H, Kang CK, Park WB, Kim NJ, Oh MD.

References

1. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020; 324(8):782–793. PMID: 32648899.
2. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054–1062. PMID: 32171076.
crossref
3. Abbas M, Robalo Nunes T, Martischang R, Zingg W, Iten A, Pittet D, et al. Nosocomial transmission and outbreaks of coronavirus disease 2019: the need to protect both patients and healthcare workers. Antimicrob Resist Infect Control. 2021; 10(1):7. PMID: 33407833.
crossref
4. Seoul National University Hospital. Status and statistics. Updated April 15, 2021. Accessed July 24, 2021. http://www.snuh.org/content/M005004002.do.
5. Ministry of Health and Welfare. Public data portal: COVID-19 infection status. Updated June 21, 2021. Accessed June 21, 2021. https://www.data.go.kr/tcs/dss/selectApiDataDetailView.do?publicDataPk=15043376.
6. Johansson MA, Quandelacy TM, Kada S, Prasad PV, Steele M, Brooks JT, et al. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Netw Open. 2021; 4(1):e2035057. PMID: 33410879.
crossref
7. Childress JF, Faden RR, Gaare RD, Gostin LO, Kahn J, Bonnie RJ, et al. Public health ethics: mapping the terrain. J Law Med Ethics. 2002; 30(2):170–178. PMID: 12066595.
crossref
8. Hunter BR, Dbeibo L, Weaver CS, Beeler C, Saysana M, Zimmerman MK, et al. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure. Infect Control Hosp Epidemiol. 2020; 41(12):1441–1442. PMID: 32741406.
crossref
9. Chung H, Kim EO, Kim SH, Jung J. Risk of COVID-19 transmission from infected outpatients to healthcare workers in an outpatient clinic. J Korean Med Sci. 2020; 35(50):e431. PMID: 33372425.
crossref
10. Basso T, Nordbø SA, Sundqvist E, Martinsen TC, Witsø E, Wik TS. Transmission of infection from non-isolated patients with COVID-19 to healthcare workers. J Hosp Infect. 2020; 106(4):639–642. PMID: 32828865.
crossref
11. Hammad TA, Parikh M, Tashtish N, Lowry CM, Gorbey D, Forouzandeh F, et al. Impact of COVID-19 pandemic on ST-elevation myocardial infarction in a non-COVID-19 epicenter. Catheter Cardiovasc Interv. 2021; 97(2):208–214. PMID: 32478961.
12. Patt D, Gordan L, Diaz M, Okon T, Grady L, Harmison M, et al. Impact of COVID-19 on cancer care: how the pandemic is delaying cancer diagnosis and treatment for American seniors. JCO Clin Cancer Inform. 2020; 4(4):1059–1071. PMID: 33253013.
crossref
13. Jeon YW, Park ES, Jung SJ, Kim Y, Choi JY, Kim HC. Protection of healthcare workers against COVID-19 at a large teaching hospital in Seoul, Korea. Yonsei Med J. 2020; 61(7):631–634. PMID: 32608207.
crossref
14. Lee H, Heo JW, Kim SW, Lee J, Choi JH. A lesson from temporary closing of a single university-affiliated hospital owing to in-hospital transmission of coronavirus disease 2019. J Korean Med Sci. 2020; 35(13):e145. PMID: 32242350.
crossref
15. Centers for Disease Control and Prevention. Interim guidance for managing healthcare personnel with SARS-CoV-2 infection or exposure to SARS-CoV-2. Updated September 10, 2021. Accessed September 16, 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html.
16. Canova V, Lederer Schläpfer H, Piso RJ, Droll A, Fenner L, Hoffmann T, et al. Transmission risk of SARS-CoV-2 to healthcare workers -observational results of a primary care hospital contact tracing. Swiss Med Wkly. 2020; 150:w20257. PMID: 32333603.
crossref
17. Heinzerling A, Stuckey MJ, Scheuer T, Xu K, Perkins KM, Resseger H, et al. Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient - Solano County, California, February 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(15):472–476. PMID: 32298249.
crossref
18. Ghinai I, McPherson TD, Hunter JC, Kirking HL, Christiansen D, Joshi K, et al. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. Lancet. 2020; 395(10230):1137–1144. PMID: 32178768.
19. Cheng VC, Wong SC, Chen JH, Yip CC, Chuang VW, Tsang OT, et al. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect Control Hosp Epidemiol. 2020; 41(5):493–498. PMID: 32131908.
crossref
20. Ng K, Poon BH, Kiat Puar TH, Shan Quah JL, Loh WJ, Wong YJ, et al. COVID-19 and the risk to health care workers: a case report. Ann Intern Med. 2020; 172(11):766–767. PMID: 32176257.
crossref
21. Baker MA, Rhee C, Fiumara K, Bennett-Rizzo C, Tucker R, Williams SA, et al. COVID-19 infections among HCWs exposed to a patient with a delayed diagnosis of COVID-19. Infect Control Hosp Epidemiol. 2020; 41(9):1075–1076. PMID: 32456720.
crossref
Fig. 1

Number of daily confirmed cases in Korea and weekly in-hospital SARS-CoV-2 exposure events by index case at a hospital, January 2020 to June 2021.

SARS-CoV-2 = severe acute respiratory syndrome coronavirus-2.
jkms-36-e274-g001
Table 1

Preventive measures for the potential exposure events of COVID-19 in hospital and its consequence, January 2020 to June 2021

jkms-36-e274-i001
Summary of the exposure events and preventive measures Total Index case of exposure events P valuea
Visitor Patient HCP
No. of exposure events 203 53 124 26
No. of exposed HCP per event, person 6 (3–14) 4 (1–6) 6.5 (3–13.25) 21.5 (9–36) < 0.001
Preventive measures, person
Passive monitoring 1,706 290 1,071 345
Active monitoring only 339 20 162 157
Active monitoring and work restriction 119 2 113 4
Self-quarantine 201 2 86 113
Consequences of preventive measures
Work restricted event 45 (22.2) 1 (1.9) 21 (16.9) 23 (88.5) < 0.001
Work restricted HCP per eventb, person 3 (1–7) 2 (2–2) 2 (1–4) 5 (2–7.5) 0.041
Duration of work restriction per eventb, days 42 (14–98) 34 (34–34) 18 (14–46) 70 (28–105) 0.028
Total duration of work restriction, person-days 3,311 34 1,683 1,594
Closing of ward/work area 10 (4.9) 0 (0) 4 (3.2) 6 (23.0) 0.002
Values are expressed as median (interquartile range) or number (%).
COVID-19 = coronavirus disease 2019, HCP = healthcare personnel.
aComparison of exposure index between patient and HCP, using the χ2 test/Fisher's exact test and Wilcoxon rank sum test, for categorical and continuous variables, respectively; bThe number of work restricted HCP and duration of work restriction were calculated for work restricted events only.
TOOLS
Similar articles